StockDuty ← Dashboard Aug 18, 2026 04:00 PM ET
CatalystFDA/Bio

MONOPAR: LICENSING AGREEMENT AND ROLLING NDA SUBMISSION SERVE AS CATALYSTS FOR 'STRONG BUY' - SEEKINGALPHA

Licensing agreement and rolling NDA submission are cited as catalysts for a 'Strong Buy' rating.

Licensing agreement and rolling NDA submission are cited as catalysts for a 'Strong Buy' rating.
Sources